Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305)

Name: Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free
Brand: Antibodies.com
SKU: A323305
Price: 295.0 USD
Availability: InStock

Enlarge Image

$295

Recombinant human monoclonal antibody to TFPI for ELISA, FACS, Functional Assay and In Vivo.

100% Guarantee

Price Match Guarantee

Delivery

Freight Charges

$40 to United States

Lead Time

7-10 Business Days

Contact Us

Telephone

+1 (314) 370-6046

orders@antibodies.com

Guarantees

100% Quality Guarantee

Price Match Guarantee

Tags:

Recombinant Antibody

Specifications

Name

Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free

Description

Recombinant human monoclonal antibody to TFPI.

Applications

ELISA, FACS, Functional Assay, In Vivo

Reactivity

Human

Host

Human

Clonality

Monoclonal

Isotype

IgG2SA - Human IgG2 with S387A mutation

Light Chains

lambda

Conjugate

Unconjugated

Purification

Protein A affinity chromatography.

Concentration

Reconstitution dependent.

Molecular Weight

This antibody has a predicted MW of 143.24 kDa.

Purity

> 90% (by SDS-PAGE and SEC-HPLC).

Product Form

Lyophilized

Reconstitution

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Formulation

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Storage

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Synonyms

Anti convertin, EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein associated coagulation inhibitor, Lipoprotein-associated coagulation inhibitor, TFI, TFPI 1, TFPI1, TFPI1_HUMAN, Tissue factor pathway inhibitor, Tissue factor pathway inhibitor (lipoprotein associated coagulation inhibitor)

Suitable Secondaries

See all Anti-Human IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation Data (2)

Enlarge Image

Figure 1: SDS-PAGE - Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305)

SDS-PAGE analysis of Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305) under reducing (R) conditions confirms that the purity of this antibody is greater than 90%.

Enlarge Image

Figure 2: Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305)

SEC-HPLC analysis of Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305) confirms that the purity of this antibody is greater than 95%.

Publishing research using Befovacimab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free (A323305)? Please let us know so that we can list the citation on this page.